Neurotech International Limited
Neurotech International Limited
Your view on NTI.AX
Overview
What the company does, where it operates, and who runs it.
About Neurotech International Limited
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Anthony Filippis
- Headquarters
- 55 Collins Street, Melbourne, VI, AU
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Anthony Filippis
- Headquarters
- 55 Collins Street, Melbourne, VI, AU
Neurotech International Limited (NTI.AX), along with its subsidiaries, is an Australian firm dedicated to the research, development, and manufacture of innovative medical devices and solutions.
The company's primary focus lies in advancing and commercializing its Mente platform, a technological system designed to monitor and facilitate home-based therapies. This includes its Mente Autism product, specifically aimed at the diagnosis and treatment of autism spectrum disorder.
Additionally, Neurotech actively undertakes various medical research projects and engineers new technological instruments. The company was established in 2016 and maintains its headquarters in Nedlands, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Neurotech International Limited. Starting points for Neurotech International Limited: beta 0.02 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Neurotech International Limited. Neurotech International Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Neurotech International Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|
| Average estimate | AUD 0.00 | AUD 0.00 |
| Lowest estimate | AUD 0.00 | AUD 0.00 |
| Highest estimate | AUD 0.00 | AUD 0.00 |
| Number of analysts | 0 | 0 |
| A year ago | −AUD 0.01 | — |
| Growth vs a year ago | +100.0% | — |
Revenue estimates
| Total | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|
| Average estimate | AUD 3.00M | AUD 14.20M |
| Lowest estimate | AUD 3.00M | AUD 14.20M |
| Highest estimate | AUD 3.00M | AUD 14.20M |
| Number of analysts | 1 | 1 |
| A year ago | AUD 0.00 | — |
| Growth vs a year ago | — | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Neurotech International Limited. Neurotech International Limited has reported as a listed company since 2016. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| AT1.AXAtomo Diagnostics Limited | Healthcare | Medical - Devices | — | ||
| BTC.AXBTC Health Limited | Healthcare | Biotechnology | — | ||
| CBL.AXControl Bionics Limited | Healthcare | Medical - Devices | — | ||
| ENL.AXEnlitic, Inc. | Healthcare | Medical - Healthcare Information Services | — | ||
| OSL.AXOncoSil Medical Ltd | Healthcare | Medical - Devices | — | ||
| PAB.AXPatrys Limited | Healthcare | Biotechnology | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| PMCBPharmaCyte Biotech, Inc. | Healthcare | NASDAQ | $3.0M | ||
| PMNProMIS Neurosciences, Inc. | Healthcare | NASDAQ | $28.2M | ||
| PMVPPMV Pharmaceuticals, Inc. | Healthcare | NASDAQ | $65.1M | ||
| POLBFPoolbeg Pharma PLC | Healthcare | OTC | $46.6M | ||
| PPBTPurple Biotech Ltd. | Healthcare | NASDAQ | $236,124 | ||
| PPCBPropanc Biopharma Inc. Common Stock | Healthcare | NASDAQ | $1.8M | ||
| PPTDFPeptiDream Inc. | Healthcare | OTC | $1.1B | ||
| PRAXPraxis Precision Medicines, Inc. | Healthcare | NASDAQ | $8.5B | ||
| PREDQPredictive Discovery Limited | Healthcare | OTC | $2,996 | ||
| PREV.CNPreveCeutical Medical Inc. | Healthcare | CNQ | $11.7M | ||
| PRLDPrelude Therapeutics Incorporated | Healthcare | NASDAQ | $191.0M | ||
| PRMEPrime Medicine, Inc. | Healthcare | NASDAQ | $694.9M | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Neurotech International Limited.